← Open Payments lookup

BELEN SACHS: Open Payments

NPI 1285238980 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,005 in 93 payments from 24 companies in 2025. Trend: 2023 $210 · 2024 $585 · 2025 $2,005

Food & beverage: $1,906Education: $99
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$253
Corcept Therapeutics12$228
Astellas Pharma US Inc4$181
ABBVIE INC.10$165
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$160
Amgen Inc.6$124
Novartis Pharmaceuticals Corporation6$120
Boehringer Ingelheim Pharmaceuticals, Inc.4$88
GlaxoSmithKline, LLC.3$75
Sumitomo Pharma America, Inc.4$71

Products named: Korlym, CAPLYTA, AIRSUPRA, JARDIANCE, LEQVIO, REXULTI, QULIPTA, Veozah.

Industry payments across CA — which companies pay providers there.